Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
3.002
-0.570 (-15.95%)
Mar 9, 2026, 2:49 PM EDT - Market open
RVPH Employees
Reviva Pharmaceuticals Holdings had 14 employees as of December 31, 2024. The number of employees decreased by 1 or -6.67% compared to the previous year.
Employees
14
Change (1Y)
-1
Growth (1Y)
-6.67%
Revenue / Employee
n/a
Profits / Employee
-$1,625,479
Market Cap
17.54M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| IO Biotech | 78 |
| Daré Bioscience | 23 |
| Genenta Science | 13 |
| VYNE Therapeutics | 13 |
| NanoViricides | 7 |
| Lexaria Bioscience | 7 |
| Intensity Therapeutics | 7 |
| Allarity Therapeutics | 7 |
RVPH News
- 2 months ago - Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum - GlobeNewsWire
- 2 months ago - FDA Asks Reviva Pharmaceuticals To Conduct Additional Phase 3 Study For Its Schizophrenia Drug - Benzinga
- 2 months ago - Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia - GlobeNewsWire
- 4 months ago - Reviva Reports Third Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 4 months ago - Reviva to Present Negative Symptom Data for Brilaroxazine in Schizophrenia from the Phase 3 RECOVER Double-Blind and Open-Label Extension Trials at the CNS Summit 2025 - GlobeNewsWire
- 5 months ago - Reviva to Participate in Key Opinion Leader Webinar Hosted by Alliance Global Partners - GlobeNewsWire
- 6 months ago - Top 3 Health Care Stocks That May Explode In September - Benzinga
- 6 months ago - Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $9 Million Public Offering - GlobeNewsWire